These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 26981939)
1. A CRISPR Way to Block PERVs--Engineering Organs for Transplantation. Salomon DR N Engl J Med; 2016 Mar; 374(11):1089-91. PubMed ID: 26981939 [No Abstract] [Full Text] [Related]
2. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Yang L; Güell M; Niu D; George H; Lesha E; Grishin D; Aach J; Shrock E; Xu W; Poci J; Cortazio R; Wilkinson RA; Fishman JA; Church G Science; 2015 Nov; 350(6264):1101-4. PubMed ID: 26456528 [TBL] [Abstract][Full Text] [Related]
3. Getting rid of PERVs. Jarchum I Nat Biotechnol; 2016 Jan; 34(1):46. PubMed ID: 26744982 [No Abstract] [Full Text] [Related]
4. Paving the Path toward Porcine Organs for Transplantation. Denner J N Engl J Med; 2017 Nov; 377(19):1891-1893. PubMed ID: 29117497 [No Abstract] [Full Text] [Related]
6. [Porcine endogenous retroviruses (PERVs) and xenotransplantation. A risk for the recipient and for society?]. Specke V; Denner J Dtsch Med Wochenschr; 2003 Jun; 128(23):1301-6. PubMed ID: 12789643 [No Abstract] [Full Text] [Related]
7. Are there better assays to evaluate the risk of transmission of porcine endogenous retroviruses (PERVs) to human cells? Denner J; Scobie L Xenotransplantation; 2019 Jul; 26(4):e12510. PubMed ID: 30932232 [No Abstract] [Full Text] [Related]
8. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9. Niu D; Wei HJ; Lin L; George H; Wang T; Lee IH; Zhao HY; Wang Y; Kan Y; Shrock E; Lesha E; Wang G; Luo Y; Qing Y; Jiao D; Zhao H; Zhou X; Wang S; Wei H; Güell M; Church GM; Yang L Science; 2017 Sep; 357(6357):1303-1307. PubMed ID: 28798043 [TBL] [Abstract][Full Text] [Related]
10. Porcine endogenous retroviruses (PERVs): adaptation to human cells and attempts to infect small animals and non-human primates. Denner J; Specke V; Schwendemann J; Tacke SJ Ann Transplant; 2001; 6(3):25-33. PubMed ID: 11899894 [No Abstract] [Full Text] [Related]
11. Reappraisal of biosafety risks posed by PERVs in xenotransplantation. Louz D; Bergmans HE; Loos BP; Hoeben RC Rev Med Virol; 2008; 18(1):53-65. PubMed ID: 17987669 [TBL] [Abstract][Full Text] [Related]
12. No in vivo infection of triple immunosuppressed non-human primates after inoculation with high titers of porcine endogenous retroviruses. Specke V; Plesker R; Wood J; Coulibaly C; Suling K; Patience C; Kurth R; Schuurman HJ; Denner J Xenotransplantation; 2009; 16(1):34-44. PubMed ID: 19243559 [TBL] [Abstract][Full Text] [Related]
13. Possible transmission of zoonoses in xenotransplantation: porcine endogenous retroviruses (PERVs) from an immunological point of view. Schmidt P; Andersson G; Blomberg J; Malmsten A; Korsgren O Acta Vet Scand Suppl; 2004; 99():27-34. PubMed ID: 15347144 [No Abstract] [Full Text] [Related]
14. No transmission of porcine endogenous retroviruses (PERVs) in a long-term pig to rat xenotransplantation model and no infection of immunosuppressed rats. Denner J; Specke V; Karlas A; Chodnevskaja I; Meyer T; Moskalenko V; Kurth R; Ulrichs K Ann Transplant; 2008; 13(1):20-31. PubMed ID: 18344940 [TBL] [Abstract][Full Text] [Related]
16. Pre-screening of miniature swine may reduce the risk of transmitting human tropic recombinant porcine endogenous retroviruses. Hector RD; Meikle S; Grant L; Wilkinson RA; Fishman JA; Scobie L Xenotransplantation; 2007 May; 14(3):222-6. PubMed ID: 17489862 [TBL] [Abstract][Full Text] [Related]
17. 7th Congress of the International Xenotransplantation Association. McKenzie IF Xenotransplantation; 2004 May; 11(3):230-2. PubMed ID: 15099201 [No Abstract] [Full Text] [Related]